AbbVie Associate Director, Field Tools & Analytics, Oncology at AbbVie leads strategy and architecture for oncology field tools supporting sales operations. The role manages a team and drives technology roadmap and cross-functional governance.
Responsibilities
Strategic Planning & Technology Roadmap
Own and author the long-range strategic plan and multi-year technology roadmap for all Oncology field tools.
Set priorities for platform investment, retirement, and consolidation decisions based on franchise needs and ROI.
Anticipate future field force needs and proactively evolve the toolset ahead of business demand.
Solution Architecture & System Design
Architect end-to-end field tool solutions, defining system design, data flows, and integration points across CRM, analytics, and reporting platforms.
Set technical and business requirement standards; final approver on major system design decisions.
Partner with IT, BTS, and OEC to ensure architecture aligns with enterprise technology standards and compliance requirements.
Governance & Cross-Functional Leadership
Serve as the executive-level point of contact and escalation path across Sales Leadership, Commercial Operations, IT, Training, OEC, Legal, and Medical/Regulatory.
Provide final sign-off on business requirements, enhancement prioritization, and project scope for major initiatives.
Lead cross-functional governance forums to align technology decisions with brand and franchise strategy.
Qualification
Salesforce/Veeva CRMData analytics platforms (TableauCore CompetenciesStrategic and long-range planningEnterprise solution architectureExecutive influence and communication
Preferred
Salesforce/Veeva CRM: strategic and architectural understanding of platform capability.
Data analytics platforms (Tableau, Power BI, QlikView) — ability to evaluate and select tools at an enterprise level.
SQL or equivalent database management — able to assess data architecture decisions.
Working knowledge of Python/R for evaluating analytical approaches (hands-on execution not required).
